Robert Hershberg
Director · RECURSION PHARMACEUTICALS, INC.
- 2025
- Oct 7, 2026
- 10
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert Hershberg files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Chad M. Robins - $37.85M in ADPT purchases and sales in the last 12 months
- Harlan S. Robins - $29.48M in ADPT purchases and sales in the last 12 months
- Julie Rubinstein - $16.25M in ADPT purchases and sales in the last 12 months
- Sharon Benzeno - $14.48M in ADPT purchases and sales in the last 12 months
- Francis Lo - $11.99M in ADPT purchases and sales in the last 12 months
- Kyle Piskel - $3.58M in ADPT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert Hershberg?
Robert Hershberg is a corporate insider, tracked as Director of RECURSION PHARMACEUTICALS, INC. (RXRX). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Robert Hershberg submitted recently?
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Has Robert Hershberg been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($1.37M) across all tracked filings.
